Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Leanne Harling moderates a discussion with David Taggart and Phillippe Kolh on the future of coronary revascularization.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - PCI
April 4, 2018
On the Pooling and Subgrouping of Data From Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Trials: A Call to Circumspection
March 28, 2018
Freemantle and colleagues discuss evidence evaluating myocardial revascularization strategies, focusing in particular on conclusions that can and cannot be drawn from subgroup analyses.
March 5, 2018
A few months after its publication, the ORBITA trial results do not seem to have filtered adequately to cardiac multidisciplinary teams worldwide.
Mortality After Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Stenting for Coronary Artery Disease: A Pooled Analysis of Individual Patient Data
February 23, 2018
In this patient level meta-analysis of 11 randomised trials, the authors compare PCI using stents with CABG. In total, almost 12,000 randomised patients were included.
January 8, 2018
A very brief editorial on frailty as a risk factor. In the time of weighing transcatheter interventions versus variable access surgical options, quantifying this physiological concept is of major importance for the cardiac teams and, importantly, the autonomy of the patient.
December 21, 2017
Interesting to read the mortality and renal morbidity of PCI after serious MI. The choice of dual primary outcome may have been an afterhought....
December 5, 2017
Patrick Myers, David Taggart, and Michael Mack discuss the recently published ORBITA trial.
June 22, 2017
The Amsterdam Investigator-initiated Absorb Strategy All-comers Trial report safety concerns identified in early results for the bioresorbable scaffold drug eluting stent. The scaffold group experienced significantly higher rates of device thrombosis than the stent group (3.5% vs 0.9%; p<0.001).
April 5, 2017
An international group of experts met at the 2017 STS Annual Meeting in Houston, Texas, to discuss the evolving practice of robotic and hybrid coronary revascularization.
Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts.
January 13, 2017
This article is a propensity matched analysis comparing patients undergoing hybrid coronary revascularization (HCR) with minimally invasive left internal mammary artery to left anterior descending artery (LAD) bypass and percutaneous coronary intervention (PCI) to non-LAD arteries to patients undergoing conventional coronary artery bypass grafting (C